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Abstract. Computer Interpretable Guidelines (CIGs) are assuming a
major role in the medical area, in order to enhance the quality of med-
ical assistance by providing physicians with evidence-based recommen-
dations. However, the complexity of CIGs (which may contain hundreds
of related clinical activities) demands for a verification process, aimed at
assuring that a CIG satisfies several different types of properties (e.g.,
verification of the CIG correctness with respect to several criteria). Verifi-
cation is a demanding task, which may be enhanced through the adoption
of advanced Artificial Intelligence techniques. In this paper, we propose
a general and hybrid approach to address such a task, suggesting that,
given the heterogeneous character of the knowledge in CIGs, different
forms of verification should be supported, through the adoption of proper
(and different) methodologies.
1 Introduction
Clinical Practice Guidelines (CPGs) can be defined as a means for specifying the
“best” clinical procedures and for standardizing them. The adoption of CPGs,
by supporting physicians in their decision making and diagnosing activities, may
provide crucial advantages, both in individualized health care, and in the overall
service offered by a health care organization. In particular, it has been shown [1]
that CPGs can improve the quality of patient care, reduce variations in quality
of care, and reduce costs. These observations justify the increasing number of
CPGs which have been defined in the last decade, covering a large spectrum of
diseases and medical procedures. Given the relevance of this phenomenon, in the
last two decades a lot of efforts have been devoted in order to provided formal
representations of guidelines, that can be treated by computer systems (usually
called Computer Interpretable Guidelines CIGs for short). As discussed in G.1
many approaches have focused on the development of guideline representation
formalisms, and/or systems to acquire, store and execute CIGs. However, the
effort in defining and disseminating CIGs has not always been coupled by a par-
allel effort in guaranteeing their “quality” [2]: despite the fact that CPGs and/or
CIGs are issued by recognized experts’ committees, they might be ambiguous or
incomplete [3], or even inconsistent. The need for guideline quality verification is
thus clearly emerging. As we will show in this paper, computer-based approaches
can provide crucial advantages in this context.
In particular, in this paper we suggest that, given the heterogeneous charac-
ter of the knowledge contained in CIGs, different forms of verifications should
be supported, demanding for an hybrid approach in which different represen-
tation formalisms are used (to properly capture different types of knowledge)
and different methodologies are devised (to properly reason with the different
formalisms). In particular, in this paper, we focus on three different forms of
verification:
1. verification that the temporal constraints in a CIG are consistent, through
constraint-based temporal reasoning techniques;
2. verification of different medical properties of a CIG (e.g., its capability of
coping with a given type of patients, or to support specific types of treat-
ments), through model checking;
3. verification of probabilistic properties of a CIG in the context of a proba-
bilistic knowledge base, through probabilistic modelling.
2 Representing and Reasoning with Temporal
Constraints
Representing and reasoning with temporal constraints is an essential feature
for computer-based approaches to clinical guidelines. In particular, a temporal
manager coping with time-related issues can be exploited in different ways in
the management of clinical guidelines. For instance, during the acquisition of
a new guideline, the consistency of the temporal constraints it contains can be
automatically checked; during the execution of a guideline on a specific patient,
the temporal manager can be used to check whether the specific actions have
been executed in such a way that the constraints in the guideline have been
respected, or to determine the times when the next actions need to be executed.
However, although many domain-independent temporal managers have been de-
vised within the Artificial Intelligence (AI) literature, and several approaches to
time-related issues have been faced within the clinical guideline literature, several
new challenges have to be addressed when dealing with temporal representation
and temporal reasoning about clinical guidelines.
2.1 Desiderata for a CIG temporal reasoner
As in most AI approaches to the treatment of time, also in the context of CIGs
we must take into account the fundamental trade-off between the expressiveness
of temporal formalisms and the computational complexity of the correct and
complete temporal reasoning algorithms operating on them.
While expressiveness is an obvious desideratum, we will now briefly motivate
the second term of the above trade-off: correctness, completeness, and tractabil-
ity. First, it is important to stress that a formalism for temporal constraints is not
very useful if it is not paired with algorithms for temporal reasoning, performing
temporal inferences on a set of constraints (expressed in the given formalism)
and/or checking their consistency. Consider, for instance, a Knowledge Base KB
containing the temporal constraints (i) and (ii) among three events A, B and C.
KB = {(i) A before B; (ii) B before C}
The constraint (iii) A before C can be inferred because it is logically implied by
(i) and (ii), so that, given KB, one can correctly assert (iii), but not (iv) A after
C, which is actually inconsistent with KB. In other words, the set of constraints
KB′ = {(i), (ii), (iv)} cannot be satisfied. Temporal reasoning is necessary in
order to support such an intended semantics. With no temporal reasoning, a CIG
may contain the above set of temporal constraints, and thus be not executable
(since there is no way of satisfying the constraints).
Of course, temporal reasoning algorithms are computationally expensive. An
important desideratum is tractability, i.e., the fact that the running time of the
algorithms grows as a fixed power of the number of the actions and/or constraints
in the knowledge base (i.e., in polynomial time).
However, temporal reasoning algorithms should also be correct, i.e., such
that they only infer constraints that are logically implied by the initial set of
constraints (in fact, correctness grants that no wrong inference is made). Com-
pleteness (i.e., the fact that all logically implied constraints are actually inferred)
is a fundamental desideratum as well, since it is essential in order to grant that
the system’s answers are fully reliable (e.g., if (iii) is not inferred from {(i), (ii)},
the answer to the question “Is (iv) consistent with {(i), (ii)}?” may be yes).
In particular, as in most AI approaches, the main task of our temporal rea-
soning algorithms is that of checking the consistency of temporal constraints in
a guideline. In fact, real-world guidelines usually consist of hundreds of actions,
often related by temporal constraints. This means that: (i) the fact that hun-
dreds of constraints are mutually consistent cannot be taken for granted and (ii)
consistency checking cannot be directly performed by physicians (and/or by a
knowledge engineer), since making explicit all the possible implications of such
a large number of constraints is an overwhelming and too complex task.
Dealing with temporal constraints in clinical guidelines: new chal-
lenges and open problems Despite the large amount of valuable works, there
still seems to be a gap between the range of phenomena covered by current
AI constraint-based approaches and the needs arising from clinical guidelines
management. In essence, while many AI approaches to temporal constraints are
focused on the treatment of a specific type of constraints only (e.g., qualitative
temporal constraints), in the CIG context several different issues and types of
constraints need to be taken into account:
(i) qualitative (e.g., at the same time) and quantitative (e.g., at least ten days
after) constraints between actions;
(ii) repeated/periodic events (and constraints between them);
(iii) all the above types of constraints may be imprecise and/or partially defined;
(iv) temporal constraints involved by part-of relations between actions in the
CIGs
(v) the distinction between (temporal constraints between) classes of actions
(e.g., an action in a general guideline) and instances of such actions.
As regards issue (iv), notice that most CIG formalisms support multiple
levels of abstraction, through the definition of composite actions, and the speci-
fication of their components. However, part-of decomposition involves temporal
constraints, since each composite action temporally contains its components. Fi-
nally, issue (v) points out that actions in CIGs can be conceived as classes of
actions, which admit multiple instantiations, whereas CIGs are applied to spe-
cific patients. This involves the treatment of some form of temporal constraint
inheritance from classes to instances. As a real example of the temporal com-
plexity of the CIG domain, consider Example 1 (which is a simplified part of a
guideline about multiple myeloma).
Example 1. The therapy for multiple myeloma is made by six cycles of 5-day
treatment, each one followed by a delay of 23 days (for a total time of 24 weeks).
Within each cycle of 5 days, 2 inner cycles can be distinguished: the melphalan
treatment, to be provided twice a day, for each of the 5 days, and the prednisone
treatment, to be provided once a day, for each of the 5 days. These two treatments
must be performed in parallel.
Temporal constraints such as the ones in Example 1 are challenging for the
constraint-based formalisms developed within the AI literature.
Obviously, the interplay between issues (i)-(v) needs to be dealt with, too.
For example, the interaction between composite and periodic events might be
complex to represent and manage. In fact, in the case of a composite periodic
event, the temporal pattern regards the components, which may, recursively,
be composite and/or periodic events. For instance, consider Example 1. In Ex-
ample 1, the instances of the melphalan treatment must respect the temporal
pattern “twice a day, for 5 days”, but such a pattern must be repeated for six
cycles, each one followed by a delay of 23 days, since the melphalan treatment
is part of the general therapy for multiple myeloma.
While some of the above issues have been treated in an ad-hoc way in the
literature, in our approach we aim at devising a general module coping in an
integrated way with all of them. The temporal knowledge server will act as an
independent module and the temporal problems in different clinical guidelines
will be delegated to such a server. The strategy we chose to adopt in order to
achieve our goal is that of devising a two-layer approach:
1. the high-level layer provides a high-level language to represent the above-
mentioned temporal phenomena and to offer several temporal reasoning fa-
cilities;
2. the low-level layer consists of an internal representation of the temporal
constraints, on which temporal constraint propagation algorithms operate.
We designed our high-level language with specific attention to modelling re-
peated actions, and in such a way that tractable temporal reasoning can be
supported. At the low-level layer, we chose to exploit as much as possible STP
(Simple Temporal Problem), a standard AI temporal reasoning framework [4].
In a certain sense, our approach uses STP as an “assembly language” and builds
an expressive “high-level temporal reasoning framework” on top of it. Obviously,
the gap between our high-level language and STP is very large. Filling such a
gap is the main contribution of our approach, and has involved the design of
suitable temporal reasoning algorithms to cope with issues (i)-(v) above, as well
as an extension of the STP framework itself (to consider labelled trees of STPs).
2.2 High-level formalism for CIG temporal constraints
Our high-level language allows one to express temporal constraints of the differ-
ent types discussed above.
Dates can be expressed by the predicate date(A, L1, U1, L2, U2), stating
that the action A must start between dates L1 and U1 and end between dates L2
and U2. Precise dates can be expressed imposing L1=U1 or L2=U2. Please note
that also unknown dates are allowed by imposing that the extremes assume value
−∞ or +∞. Other constructs include the predicate duration(A, L, U), stating
that the duration of action A must be included between L and U, delay(P1,
P2, L, U), stating that the delay between P1 and P2 must be between L and
U, where P1 and P2 are time points (i.e., starting or ending points of actions).
Also qualitative temporal constraints such as “before”, “after”, “during”
are supported by our language: in fact all and only the qualitative constraints
that can be mapped to conjunctions of STP constraints are supported.
For representing composite actions we support the predicate partOf(A’, A),
stating that the action A’ is part of the composite action A. Please note that the
partOf relation induces a temporal constraint between the actions: i.e., action
A’ must be during action A. The predicates described above can be also used
for representing temporal constraints between instances of actions.
In order to describe the relation between instances and classes, we need to
introduce a further predicate, instanceOf(I, A, p) to represent the fact that
the instance of action I is an instance of the class of actions A. If A is a repeated
action, then p represents the fact that I is an instance of the pth repetition of A
(if A is not a repeated action, p = 0).
Regarding repetition of actions, we provide the predicate repetition(A,
RSpec), to state that the (possibly composite) class of action A is repeated
according to the specification RSpec. RSpec is a recursive structure of arbitrary
depth of the form
RSpec = 〈R1, . . . , Rn〉,
where each level Ri states that the actions described in the next level (i.e., Ri+1,
or by convention the action A, if i = n) must be repeated a certain number of
times in a certain time span. To be more specific, any basic element Ri consists
of a quadruple
Ri = 〈nRepetitionsi, I-Timei, repConstraintsi, conditionsi〉,
where the first term represents the number of times that Ri+1 must be repeated,
the second one represents the time span in which the repetitions must be in-
cluded, the third one may impose a pattern that the repetitions must follow,
and the last one allows to express conditions that must hold so that the rep-
etition can take place. Informally, we can roughly describe the semantics of a
quadruple Ri as the natural language sentence repeat Ri+1 nRepetitionsi times
in exactly I-Timei, if conditionsi hold.
A detailed treatment of such a specification is outside the goals of the current
paper. Indeed, in [5] the expressiveness of the language for repetitions has been
studied, on the basis of both the classification criteria provided by Egidi and
Terenziani [6, 7] and by Bettini [8].
Additionally, in [5] the semantics of such specifications has been formally
studied.
For example, the melphalan treatment in Example 1 can be represented as
Repetition(melphalan, 〈R0 = 〈5, 5d, , 〉, R1 = 〈2, 1d, , 〉〉), meaning that the treat-
ment is composed by two levels: R0 states that R1 must be repeated five times
in five days and R1 states that melphalan must be administered twice a day.
2.3 Reasoning with temporal constraints in CIGs
Regarding the instances of actions, we designed the high-level language in such
a way that all constraints can be mapped onto bounds on differences and, thus,
internally represented as a “standard” STP framework [4].
However, regarding the classes of events, while dates, delays, durations and
qualitative temporal constraints might be represented with an STP about classes,
it is not possible to represent in such a basic way also the temporal constraints
about repeated/periodic and/or composite actions. We thus introduce STP-
trees, as a suitable low-level representation of temporal constraints, on which
temporal reasoning algorithms can operate.
STP-tree In our approach, the overall set of constraints between actions in the
CIG is represented by a tree of STPs (STP-tree henceforth). The root of the
tree is the STP which represents the constraints between all the actions in the
guideline, except the components of repeated actions.
The STP-tree corresponding to a guideline can be automatically constructed
on the basis of the temporal constraints in the guideline (expressed using the
high-level language in Subsection 2.2) by executing an algorithm which oper-
ates recursively, from the root to the leaves, by putting in each STP-node all the
actions except the components of repeated actions, which are represented in sep-
arate STP-nodes. On the other hand, the partOf relations not involving repeated
actions are represented in the same STP as the composite action by adding to
such an STP-node the constraints that all the components are contained into
the corresponding composite action.
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Fig. 1. STP-tree for the multiple mieloma chemotherapy guideline in Example 1. Thin
lines and arcs between nodes in a STP represent bound on differences constraints. Arcs
from a pair of nodes to a child STP represent repetitions. Arcs between any two nodes
X and Y in a STP of the STP-tree are labeled by a pair [n, ] re resenting the minimum
and maximum distance between X and Y. Sch, Ech, Smc, Emc, Spc, Epc, Sm, Em, Sp
and Ep s and for the starting (S) nd e ding (E) points of chemotherapy, melphalan
cycle, prednisone cycle, melphalan treatment and prednisone treatment, respectively.
To summarize, in the STP-tree there are as many STP-nodes as the number
of repeated actions, and in each STP-node there are as many actions as the
number of actions in the guideline that are parts of the repeated action that the
STP-node represents. Specifically, each action is represented in the STP-node
as a pair of time points, while constraints between (not repeated) actions are
represented by arcs connecting them.
For instance, in Figure 1, we show the STP-tree representing (at the low-
level) the temporal constraints in Example 1.
Additionally, an independent STP must be used in order to represent the
temporal constraints about the specific instances of the actions of the guidelines,
as emerging from executions of the guidelines on specific patients.
Checking the consistency of a guideline Given an STP-tree, it is possi-
ble to check its consistency in an intensional way, i.e., without generating every
repetition of repeated actions. However, it is not sufficient to check the consis-
tency of each STP contained in the STP-nodes separately. In such a case, in
fact, we would neglect the repetition/periodicity information. Temporal consis-
tency checking, thus, proceeds in a top-down fashion, starting from the root of
the STP-tree towards its leaves. Basically, the root contains a “standard” STP,
so that the Floyd-Warshall’s algorithm can be applied to check its consistency.
Thereafter, for each node X in the STP-tree (except the root), we proceed as
shown in the algorithm STP tree consistency (see Algorithm 1).
Algorithm 1 Algorithm for checking the consistency of a guideline (represented
as an STP-tree).
function STP tree consistency(X : STPNode,
RSpec = (R1 = 〈nRepetitions1, I-T ime1, repConstraints1, conditions1〉, . . . ,
Rn = 〈nRepetitionsn, I-T imen, repConstraintsn, conditionsn〉)) : STP
1: check that the repetition/periodicity constraint is well-formed (i.e., that repetitions
nest properly)
2: compute Max, i.e. the maximum duration of a single repetition of X according to
RSpec
3: impose in X that the maximum distance between each pair of points is less or
equals Max
4: X ← FloydWarshall(X)
5: if X = INCONSISTENT return INCONSISTENT else return X
STP tree consistency takes in input the STP-node that must be checked (i.e.
X) and the repetition/periodicity constraint (i.e., the repetition specification in
the arc of the STP-tree entering node X), and gives as an output an inconsistency
or, in the case of consistency, the local minimal network of the constraints in
X considering also the repetition/periodicity constraints. In step 1 it checks
whether the repetition/periodicity constraint is well-formed, i.e. if it is consistent
when it is taken in isolation (e.g., I-Time2 must be contained into I-Time1). In
step 2 it computes the maximum duration of a single repetition. This is obtained
by considering the time that allows to perform a repetition assuming that all
the other repetitions have the minimum possible duration. In step 3 it adds to
the STP X the constraints stating that the maximum duration of X must be
the computed maximum duration of a single repetition of X. Finally, in step
5 it checks the consistency of the augmented STP X via the Floyd-Warshall’s
algorithm.
Property. STP tree consistency is correct and complete (see [5]). Consider-
ing that the number of nesting levels, in the worst case, is less than the number
of classes, the algorithm is dominated by step 4, that is O(C3), where C is the
number of actions in the guideline.
Reasoning with the executions of the guideline We have also devised
an algorithm for checking the consistency of the execution of a guideline in-
stance with respect to its related guideline. In our work, as in most approaches
to clinical guidelines, we suppose that one has full observability of instances
(i.e., all the instances of actions which have been executed have been observed
and inserted into the knowledge base), and that, for each instance, one knows
the corresponding class of actions and/or repetition in the guidelines. The pro-
cedure integratedConsistency accepts three parameters: T (the STP-tree that
describes the constraints about classes of actions in the guideline), E (the STP
that describes the temporal constraints between the instances of actions – i.e.,
the actions that have been executed on specific patients), and NOW, that cor-
responds to the time of the present. The basic idea is to:
(a) check that in the executionSTP there are all and only the instances that the
STP-tree predicts to be. Possible missing instances are hypothesized because
they may happen in the future;
(b) inherit the repetition/periodicity constraints and the temporal (non-periodic)
constraints from the classes to the instances;
(c) propagate the temporal constraints on the executionSTP, thus obtaining the
minimal network [4];
(d) check whether the hypothesized instances expected in the future may actu-
ally start in the future (i.e., after NOW).
Property. Let us denote with C the number of classes in the STP-tree,
with I the number of instances. We have that the complexity of the procedure
is O(max{I3, C3}). Also, integratedConsistency is correct and complete as re-
gards consistency checking of the constraints among the instances and among
the classes in the STP-tree [5].
3 Clinical Guideline Verification
The verification capabilities concerning the general properties of CIGs and their
execution available in the conventional CIG management systems in the litera-
ture are usually rather limited. In many cases, such systems do associate only
very specific and ad-hoc inferential mechanisms to the knowledge represented
in the guideline. To overcome such limitations, the adoption of theorem proving
techniques has been proposed within the Protocure European project starting in
2003 [2, 9]. As an alternative of the theorem-proving methodology, the adoption
of model-checking techniques has been independently proposed a few years later
in the Protocure project [10] and in our project GLARE [11–13], mainly moti-
vated by the simplicity and efficiency of model-checking techniques with respect
to the theorem proving approach [14].
Specifically, in our approach we propose a modular solution in which a CIG
management system is loosely coupled with a model checker via a translator,
which maps any guideline expressed in the formalism of the CIG management
system into the formalism of the model-checker. In such a way, the advantages
of adopting a CPG management system from one side, and a general-purpose
model-checker on the other side are retained and combined. In particular, once
the mapping has been defined, any class of properties that can be formalized
in the logic of the model checker can be easily verified, without requiring the
definition of a new verification software module from scratch. This obviously
facilitates a real interaction between the physician examining the CIG and the
system itself. Thanks to its modularity, such an approach can be easily imple-
mented, since it does not require any modification to either the CIG management
system or the model-checker.
Although our proposal is mostly application-independent, as a proof of con-
cept, we have integrated within the system GLARE [15] a verification tool
which models a CIG in Promela, the specification language of the model checker
SPIN [16], and verifies the CIG properties to be checked by formalizing them as
Linear time Temporal Logic (LTL) formulas.
3.1 Integrating GLARE with SPIN
We have applied the general methodology introduced above in order to couple
GLARE with the model checker SPIN. We have implemented a translator which
takes in input a GLARE CIG, expressed in the XML format, and transforms it
into the corresponding CIG in the Promela language. Analogously, the patient
data (in XML) are also translated into the Promela language.
Promela allows a high level model of a distributed system to be defined by
modeling each process in an extended pseudo C code, including synchroniza-
tion primitives and message exchange primitives. Promela provides the usual
if-then-else and iteration constructs of imperative languages, but it also allows
for goto statement (allowing jumps to labels), for the non-deterministic choice
construct, as well as for the parallel execution of processes. Processes may share
global variables and they also may exchange messages through asynchronous
communication channels.
In the following, we briefly describe the general principles we adopt to convert
a GLARE CIG into the corresponding agent-based program in the Promela
language. First, we describe how a CIG is mapped to a set of interacting processes
(called agents henceforth), i.e. to a set of Promela processes and to a set of proper
synchronization primitives and message exchange primitives. Then, we shortly
describe our translator module.
Guidelines as agents Obviously, the basic object we need to represent in
Promela for the purpose of verification is the CIG itself. A CIG can be seen as
a set of actions, to be executed in the order specified by a set of control flow
primitives. We have mapped each construct (action or control flow primitive) in
the CIG to a Promela statement or to a Promela piece of code.
However, CIG execution is a complex phenomenon that cannot be modeled
just by representing the CIG per se.
In the following, we propose a possible, more realistic way of capturing the
dynamics of the CIG and of its execution environment, based on the idea of
modeling a set of processes, whose interaction models the CIG execution itself.
One of the required processes, which we will call agents, is of course the CIG
itself. The other agents represent the (human or not) components interacting
with the CIG at execution time.
In particular, the Database agent has to be represented. Actually, patient’s
characteristics need to be specified, and, rather naturally, we characterize a
patient by relying on her data, which are typically maintained in the clinical
database. The Database agent thus provides data on demand, and is able to
store new data values.
Updated data values are sometimes obtained from additional sources (e.g.
from the hospital laboratory service). We have generically modeled such sources
and services by means of a further agent, called Outside world.
Last but not least, CIG execution is performed by a physician; therefore, the
physician’s behavior needs to be modeled as an agent as well. In particular, we
have identified two main tasks that the Physician agent is expected to cover when
applying a CIG to a specific patient. Obviously, it is required to make decisions,
i.e. it has to select exactly one diagnosis or therapy, among a set of alternative
ones. Moreover, it has to evaluate data recency and reliability: if a data value,
extracted from the database, is judged as unreliable or not up-to-date (i.e. too
old), the Physician agent has to rise the problem, thus triggering the generation
of a newer data value from the outside world.
In summary, the model of the distributed system we propose to simulate
CIG execution can be described by the interaction among the following agents,
interpreted as Promela processes:
1. the Guideline agent, which models the overall behavior of the CIG;
2. the Database agent, which models the behavior of the patient database,
allowing for data insertion and retrieval;
3. the Outside agent, which represents the outside world and provides up to
date values for patient data (together with the time of their measurement)
when they are not already available in the database or are evaluated as
being not reliable by the physician. It also stores data in the database, and
simulates the execution of actions by reporting their success or failure;
4. the Physician agent, which interacts with the CIG by evaluating the patient
data, choosing among the different alternative feasible paths as a physician
would do, and judging data reliability. Observe that we model the Physician
agent as a non-deterministic process, since it is not possible to know a-
priori all the possible choices of physicians in all the possible situations. We
therefore model the uncertainty about the choice of physicians using non-
determinism: from the point of view of the simulation, choices are taken
randomly by the Physician agent.
The translator As explained above, we have defined a translator which takes a
set of XML documents representing any GLARE CIG and automatically trans-
forms them into the corresponding CIG in the language Promela.
A CIG in GLARE is a hierarchical graph, in which it is possible to have
composite actions (i.e. plans), which can be defined in terms of their components
via the has-part relation. In the XML document such a structure is maintained.
Thus, the translator works as a top-down parser.
In particular, the translator takes in input a graph defined as a couple 〈N,E〉
(where N is the set of nodes and E is the set of edges), which is the XML
document representing the CIG, and a vocabulary V , which contains the medical
data information. To make the translation, the parser visits the graph twice. The
first time it makes a preprocessing in order to obtain the data concerning the
requests of information.
In the second step, the parser visits the graph for the second time, in order
to build the agents which model the CIG behavior.
3.2 CIG verification in SPIN
After the translation, SPIN can be used in order to “reason” about the guidelines.
In particular, verification can be managed by expressing properties in LTL, and
giving them in input to SPIN, together with the representation of a guideline
obtained through the translation process. SPIN translates each Promela process
into a finite automaton, and the global behaviour of the system is obtained
by computing an asynchronous interleaving product of automata. The resulting
automaton represents the global state space of the system (the model containing
all the possible executions - runs - of the CIG) and can be built on-the-fly during
the verification process. The correctness claims, that have to be checked on the
model of the system, are then specified as temporal logic formulas in LTL. Given
a property (specification) as an LTL formula, SPIN verifies if the property is true
on all the executions of the system. Namely, each run of the system is regarded
as a linear temporal model, on which the truth of the property is verified from
the initial state.
As a matter of fact, temporal logics such as LTL allow one to express a wide
range of formulas. Such an expressiveness and generality motivates a deeper
analysis of what kinds of properties, expressible in LTL, are useful in the CIG
context. We show some examples, dividing the properties on the basis of the CIG
life-cycle phases. Specifically, we single out three main phases (namely, (1) design
and acquisition, (2) contextualization, and (3) execution), and we highlight how
verification can be fruitfully exploited in each phase.
For the sake of exposition, we describe the properties to be verified by dis-
tinguishing two components: (1) a quantifier on “runs”: ∀, stating that we verify
if the property holds on all the runs, and ∃, stating that we look for one run
satisfying the property; (2) an LTL formula. In the following we assume that the
variable “done” in each state is set to the action performed in that state.
Design and acquisition CIGs are usually defined by a national or international
committee of specialists, and can be acquired into a computer-based system,
usually through a cooperation between some specialists and some knowledge
engineers. In such a phase, verification through model checking is useful in order
to take into account at least two different classes of properties, namely structural
properties and medical validity properties. In particular:
(i) Structural properties concern the existence of the appropriate clini-
cal requirements. These properties regard the actions, conditions and paths of
actions in the CIG considered “per se”, without any reference to the specific
context of execution and to the specific patients on which the CIG will be ap-
plied, and are relevant in order to ensure the appropriate management of any
patients.
Example: verify that any run contains antibiotic treatment (community ac-
quired pneumonia guideline)
< ∀run, (done = antibiotic treatment) >
Comment: The property evaluates to true if all possible runs contain a state in
which an antibiotic treatment is administered.
Relevance: The antibiotic treatment is mandatory in the case of community
acquired pneumonia.
(ii) Medical validity properties concern both the exclusion of dangerous
treatments and the inclusion of the most appropriate treatments for the con-
sidered class of patients. These properties are relevant in order to ensure best
practice.
Example: verify that whenever hepatic encephalopathy is present, diuretics
are not administered (ascites guideline)
< ∀run, liver state = encephalopathy → 2(done 6= diuretics administration) >
Comment: Diuretics are contraindicated in hepatic encephalopathy.
Relevance: Diuretics can worsen the liver perfusion and precipitate the en-
cephalopathy or worsen its severity.
Both structural and medical validity properties are verified during the acqui-
sition phase, in which both medical experts and knowledge engineers are usually
involved. Specifically, medical experts can identify the structural and validity
properties that are relevant for the CIG under consideration, and knowledge
engineers can formulate and run the corresponding verifications, reporting the
results to the experts. In case the checks show that a desired property does not
hold, the domain experts should identify the appropriate corrections to the CIG,
which will be modified accordingly, in cooperation with the knowledge engineers.
Contextualization Once a CIG has been defined and acquired (e.g., by a
national or international committee), it has to be applied to several different local
structures (e.g., hospitals). Unfortunately, in several cases, the original CIG is
too “general” to be applied on any specific environment. For instance, depending
on the local availability of resources, certain actions of a general CIG cannot be
executed in specific contexts (e.g., small hospitals). A phase of contextualization
is thus usually needed: when a new CIG is introduced in a hospital, the medical
personnel can use verification (possibly in cooperation with knowledge engineers)
in order to identify which resources the CIG (or specific paths of the CIG itself)
requires. Specifically:
(iii) Contextualization properties concern the resources needed for the
CIG execution and can be checked to adapt the CIG to locally available re-
sources.
Example: verify that there is a run in which the CT scanner is not used
(ischemic stroke guideline)
< ∃run,2done 6= TC >
Comment: If this condition holds, the GL (or, at least a part of it) can be applied
also in hospitals where the case the CT scanner is not available.
Relevance: The CT scanner is very important in some cases but not always
accessible.
The results of such verifications can be used for modifying the original CIG,
or for improving the hospital resources, in order to conform the hospital to the
CIG requirements (to grant the best practice). In the last case, the intervention
of administrator personnel is also necessary.
Execution Finally, the acquired and contextualised CIGs are used in clinical
practice. In such a case, a specific user-physician selects and applies a specific
CIG to a specific patient. Verification is a crucial support also in such a phase:
(iv) Properties concerning the application of a CIG to a specific
patient allow to check which are the best actions (as indicated in the CIG)
to be executed on the patient at hand, on the basis of the patients status and
symptoms; they also allow to check whether the CIG (or some specific path of
it) contains the specific actions which the user-physician expects to be necessary
for the patient at hand.
Example: verify that there is a treatment in which growth factors are admin-
istered, when leukopenia appears (lymphoma treatment guideline)
< ∃run,2(leukopenia value = present→
 (done = growth factors administration)) >
Comment: The growth factors administration can positively reduce the duration
of the leukopenia and the risk of infections.
Relevance: If leukopenia is not severe, there are also alternative treatments to
the administration of growth factors (e.g., expectant treatment and monitoring).
That is why we check the existence of one run in which (in a given status) growth
factors are administered, without forcing that they are administered in all runs
(in contrast with the verification above).
4 Probabilistic Verification
While many of the logical verification methods that have been proposed can be
used to verify existing guideliens, a possible shortcoming of the logical methods
is that they cannot deal with uncertainty stemming from the use of scientific
evidence. On the other hand, many probabilistic methods do not have the rep-
resentational benefits of logic for modelling temporal constraints between tasks.
In the last few years, there has been a surge of interest in the field of statistical
relational learning [17]. In this endeavour, many probabilistic logics have been
developed. We believe that these kind advances provide the right ingredients to
represent and reason with such heterogeneous medical knowledge.
We think this type of probabilistic verification could particularly be impor-
tant during the development of a CIG. In this section, we will first introduce
a language that can be used to represent guidelines and a probabilistic knowl-
edge base. After this, we show that such a language may be used to represent
a guideline. Finally, we illustrate the approach by means of an example in the
development of a hypothetical guideline for diabetes mellitus type 2.
4.1 Causal probabilistic decision logic
We use CP-logic as a starting point, which we will briefly introduce. CP-logic
theories consist of a multi-set of causal probabilistic laws (CP-laws), which are
statements of the form:
∀x : (h1 : α1) ∨ · · · ∨ (hn : αn)← b1, . . . , bm (1)
where the α1 : [0, 1] are probabilities with
∑
αi ≤ 1, n ≥ 1, and m ≥ 0. In this
formula, hi and bj are atoms, that is, expressions of the form p(t1, ..., tm) in which
p/m is the name of a predicate of arity m and ti are terms, i.e., constants or
variables. We call the set of all (hi : αi) the head of the law, and the conjunction
of literals bi the body of the law. We also refer to all hi as consequences, and
to bi as conditions. If the head contains only one atom h : 1, we may write it
as h. Informally, the law states that in case the body is true, then at most one
of the consequents becomes true, i.e., a consequent is caused by the body. The
probabilities in the consequents reflect the probability that the body causes the
consequent to become true.
The semantics of CP-logic relies on the notion of a Herbrand interpretation.
This is essentially a set of ground atoms that can be constructed using the con-
stant and predicate symbols occurring in the theory. We shall denote Herbrand
interpretations by M and we shall write M |= ϕ if the logical formula ϕ satisfies
the interpretation M . Moreover, for simplicity of presentation, we assume a finite
set of constants and also that all laws are grounded, i.e., each law is replaced by
the set of laws where the variables are replaced by constants. For more details
on notions of first-order logic and logic programming, we refer to [18].
CP-logic was designed as a probabilistic logic for modelling causal processes.
Actions, too, can be incorporated into these processes, in which case CP-logic
requires that the actions that agents take when the body holds is modelled using
probabilities. In some cases, one wants to abstract from such actions, for example,
to abstract from scheduling decisions when reasoning about concurrent systems.
In other situations, there is no probabilistic information about the behaviour
of agents, e.g., the course of action of physicians. To be able to model this, we
introduce non-determinism into the CP-logic models by adding causal decision
laws (CD-laws) to CP-logic. The resulting language is called Causal Probabilistic
Decision Logic (CPDL).
Causal decision laws (CD-laws) are of the form:
∀x : h1 ∨ · · · ∨ hn ← b1, . . . , bm (2)
with n ≥ 1 and m ≥ 0, which can be seen as CP-laws without any probabilities
attached to the elements in the head of the clause. The intuitive reading is also
similar to CP-laws, i.e., b1, . . . , bm causes one of the heads, but in this case non-
deterministically. That is, again exactly one of the heads is caused by the body,
but we do not know which one and also do not know the probabilities.
To obtain a probability distribution for CPDL, the nondeterminism has to be
resolved. For this we introduce a policy, which is a function pi which maps each
ground CD-law to one of its heads. For this function it holds that if pi(R) = hi,
then R is a CD-law of the form:
h1 ∨ · · · ∨ hn ← b1, . . . , bm.
and 1 ≤ i ≤ n. The intended semantics is that if (b1, . . . , bn) holds, and pi(R) =
hi, then hi becomes true. Therefore different groundings will produce different
choices (as in CP-logic).
In [19], the semantics of this CP-logic is presented by relating the set of laws
to a possible probabilistic causal process. We briefly introduce the semantics
of CPDL in the spirit of CP-logic. Consider a CPDL theory T , a policy pi, a
Herbrand interpretation M , and a grounded law Rk where Rk = head ← body.
If Rk is a CP-law and M |= body, then the law can be applied for hi : αi ∈ head,
which we denote by M −→αi M∪{hi}. A CD-law can be applied if also pi(Rk) =
hi holds, which is denoted by M −→ M ∪ {hi}. We then write M −→∗p M ′ if
there exists a chain of applications of laws from M to M ′ such that each ground
law has been applied at most once, no other laws can be applied, and p =
∏
i αi
where αi are all the probabilities of the applied CP-laws. CPDL defines a joint
probability distribution over Herbrand interpretations given a interpretation M
by Ppi(M
′) =
∑
M−→∗pM ′ p. Note that a uniform probability distribution over
heads in a CP-law is quite different from a CD-law. If a theory consists of CP-
laws, then this models a unique probability distribution. For theories that contain
CD-laws, each policy defines a possibly different probability distribution over the
Herbrand interpretations.
As a first-order language, CPDL is of course sufficiently rich to model discrete-
time models. For representation, we propose a small syntactical extension to the
language, which we call CPDTL (Causal Probabilistic Decision Time Logic). We
introduce a predicate −→· which denotes a transition, i.e., −−→a(v) denotes that a(v)
holds after a transition. A CPDTL theory contains a set of CPDL laws which
may contain −→· , and also a set of initial laws of the following form:
(ai(vi1)) : αi1 ∨ · · · ∨ (ai(vin)) : αin ←M
where M is called the starting state. A CPDTL theory can be mapped to CPDL
by replacing all predicates a/m by a/m+1 and indexing the predicates by time.
Predicates in the initial law get indexed by time 0, i.e., ai(vi) becomes ai(vi, 0);
the atoms
−−→
a(v) are replaced by a(v, t+ 1); all other atoms a(v) are replaced by
a(v, t). Consider the following example to illustrate this language.
Example 2. Each year, you can decide whether or not to get a flu shot, which
affects the chance of becoming infected with influenza (with probability 0.01
when vaccinated, 0.1 when not vaccinated). Influenza might cause other disor-
ders, such as angina (with probability 0.2) and pneumonia (with probability 0.1).
Angina causes pneumonia (with probability 0.1), and vice versa (with probabil-
ity 0.8). Pneumonia might be lethal (with probability 0.01), although there is
also a chance of dying of other causes (with probability 0.001). This medical
knowledge of influenza can be represented in CPDTL as follows.
state(alive)←M
vaccine(true) ∨ vaccine(false)← state(alive)
disorder(influenza) : 0.1← vaccine(false)
disorder(influenza) : 0.01← vaccine(true)
disorder(angina) : 0.2 ∨ disorder(pneumonia) : 0.1
← disorder(influenza)
disorder(pneumonia) : 0.1← disorder(angina)
disorder(angina) : 0.8← disorder(pneumonia)
−−−−−−−−→
state(dead) : 0.01 ∨ −−−−−−−−→state(alive) : 0.99
← disorder(pneumonia)−−−−−−−−→
state(dead) : 0.001 ∨ −−−−−−−−→state(alive) : 0.999
← state(alive)
Note that the choice for vaccination has been represented by a CD-law, whereas
the rest of the knowledge is represented by a set of CP-laws.
While it is already obvious in this specification that vaccination increases chances
of survival, medical researchers are often more interested in relative measures
such as the relative risks and the number needed to treat (NNT), i.e., the number
of patients who need to be treated to prevent one additional bad outcome. For
example, if vaccination decreases the chance on flu from 0.1 to 0.01, then the
NNT is 1/(pmax−pmin) = 1/(0.1−0.01) ≈ 11, which means that if 11 people are
vaccinated, 10 people are not expected to benefit. The NNT for preventing death,
however, is not so clear given the interactions between variables. If, however, we
would have the minimal and maximal probability of death, then such measure
can be easily computed (similar for other relevant measures). If there is one
binary decision variable, then this can be solved by computing the outcome of
both decisions, but more generally this approach is not feasible.
4.2 Application to guideline verification
The idea of probabilistic verification is now as follows. CPDTL is expressive
enough to formalize a non-deterministic automaton using CD-laws. Hence, in
principle, a SPIN model derived from a GLARE CIG as described in section 4.2
can be represented in CPDTL. Furthermore, probabilistic information may be
combined with this model. The resulting model can be mapped to a probabilistic
automaton that can be used to reason with.
Probabilistic automata Probabilistic automata model discrete-time stochas-
tic systems consisting of a (finite) set of states S, an initial state s0 ∈ S, a
(finite) set of actions A and transition probabilities P : A× S × S → [0, 1] such
that for all a and s, P(a, s, s′) is a probability distribution over s′. Furthermore,
we assume a labelling function L : S → 2AP that labels each state with a set of
atomic propositions that are true in that state.
A policy pˆi : S → A is used to decide which action is taken in a state. Given
this, a PA can be interpreted as a joint probability distribution over states and
actions indexed by time. It is clear that P (S0 = s0) = 1. Furthermore, the
transition probabilities define the conditional probability P (St+1 = s
′ | St =
s,At = a) = P(a, s, s
′). Finally, we can interpret policies as a deterministic
probability distribution P (At = a | St = s) = 1 if pˆi(s) = a.
Given the assumptions above in addition to a Markov assumption, the joint
probability of a path, given a policy pˆi, is the product of all transitions that occur
in the path, i.e., P (M, s0, . . . , sn) =
∏n
t=1 P(pˆi(st−1), st−1, st). In the formal
methods community, standard solvers exist to compute lower and upper bounds
on probabilities. For this paper, we use the most well-known probabilistic model
checker prism [20].
Translation To model a CPDTL theory as a PA, we require that we have a set
of attributes Attr, with a known domain dom(a) for a ∈ Attr, corresponding to
a set of predicates in the theory for modelling a state. It should hold that these
attributes in the theory are both mutually exclusive and complete. States can be
defined as the set of attributes with particular values. As in many other prob-
abilistic logics, this property is not being checked by the system, but should be
ensured by the modeller. However, if this holds, then consider a CPDTL theory
T with dynamic attributes Attr for which we define a PA M = 〈S, s0, A, L,P〉
such that:
– s ∈ S iff s = M or for all a ∈ Attr there exists a unique v ∈ dom(a) such
that a(v) ∈ s
– A = {pi | pi a CPDL policy for T}
– s0 = M
– L(s) = s
– For all states si, sk ∈ S and policies pi ∈ A:
P(pi, si, sk) =
{
Ppi(
−→sk | si) if si 6= sk
1−∑j 6=i Ppi(−→sj | si) if si = sk
Note that in this definition, the probability of not transitioning to a new state
means that you will end up in the same state, which can be seen as a frame axiom.
This is a small semantic difference with the original semantics. However, when
the transitions are fully specified, i.e., for all pi and si holds
∑
k Ppi(
−→sk | si) = 1,
such as in Example 2, then the models will be equivalent in the following sense.
Proposition 1 (fundamental connection PA and CPDTL). Given a CPDTL
theory with state variable s made from the dynamic attributes such that the tran-
sitions are fully specified. Let PCPDTL be the corresponding probability distribu-
tion and PPA the probability distribution of the corresponding PA. Then
PPA(M, S0 = s0, . . . , St = s) = PCPDTL(s(t))
Note that for representation, it can be quite useful to have the frame axiom.
Example 3. The knowledge base presented in Example 2 can be graphically rep-
resented as a probabilistic automaton as follows:
{state(alive)}
M
{state(dead)}
1 0.0011[vaccine(false)]
0.9989[vaccine(false)]
0.0010[vaccine(true)]
0.9990[vaccine(true)]
1
The state of the PA is defined by the predicate ‘state’ and knowledge that
models transitions have been abstracted into a single number for each possible
policy choice.
4.3 Case study
Using the machinery that has been introduced so far, we investigate a problem
of deciding an appropriate treatment for diabetes mellitus type 2. This model
is significantly more complex than the influenza example as diabetes is a com-
plicated disease: various metabolic control mechanisms are deranged and many
different organ systems may be affected by the disorder. For the individual pa-
tient, there is a lot of uncertainty to which extent physiological phenomena occur,
which has an impact on the effectiveness of a treatment. We will focus here on a
well-known drug called metformin, which is commonly prescribed as the primary
oral anti-diabetic, of which the efficacy is known [21]. Moreover, we consider a
genetic variation in the encoding of a protein called organic cation transporter 1
(OCT1) which affects the response to metformin [22]. Such knowledge was used
to build a set of logical sentences that can be used to explore a simple model
of a guideline that recommends treating diabetes with metformin. We answer
a number of relevant questions that may come up during the design of such a
diabetes guideline. In total, the knowledge base consists of about 50 rules and
10 facts, of which most rules are CD-laws (describing the guideline) and about
10 rules describing background knowledge based on medical literature. For ex-
ample, it is stated as two CP-laws that there is a 20% chance of carrying the
genetic OCT1 variation:
oct variant(true) : 0.2 ∨ oct variant(false) : 0.8←M−−−−−−−−−−→
oct variant(X)← oct variant(X)
From a practical modelling point of view, variables are not restricted to a finite
domain using this logic. For example, in this application, it is convenient to
count the number of days that metformin has been given to a patient. This is
easily modelled using a counting variables applied defined by:
−−−−−−−−−→
applied(T+1)← state(activated), applied(T)
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Fig. 2. Probabilistic simulation of metformin application with minimal (min) and max-
imal (max) probabilities. Furthermore, we consider a model where the physician acts
with a probability p = 0.5.
which says that, whenever metformin is given to the patient (state(activated)),
then the counter applied is incremented. While this results in an infinite number
of states, queries are always related to a time-point. Hence, we can dynamically
restrict the domain of T to an appropriate upperbound.
Given such a model, we show a number of queries that explores relevant
questions for the practical treatment of diabetes mellitus type 2 patients with
metformin.
Question 1: How long should metformin be applied before it can be decided to
stop the treatment? There is a trade-off for deciding to stop a treatment: if the
treatment with oral anti-diabetics is stopped too early then patients may be
injecting themselves with insulin for no good reason; if the treatment is stopped
too late, then patients who need treatment with insulin are not treated appro-
priately. In Figure 2, we plot minimal and maximal probabilities over time. In
this case, minimal probabilities are zero, because the guideline did not force the
physician to start treatment within a certain time bound, which can be consid-
ered a shortcoming of the guideline. We therefore consider another choice where
physicians start treatment every day with a certain probability, which in this
case is set to a probability 0.5. Furthermore, in Figure 3, we plot a number of
dose-response curves for different patients (also with a physician that acts with
probability 0.5). For people with an initial low fasting plasma glucose (FPG), the
effect of treatment is relatively quick, whereas people with an initial high fasting
plasma glucose, the effect is much slower and might not be effective at all even
after prolonged treatment. Hence, a recommendation of metformin should take
the differences with respect to the baseline fasting plasma glucose into account.
Question 2: What improvement could we gain using genetic information? As
the OCT1 protein affects the efficacy of metformin, it might be useful to test
whether a patient has a variation in this gene before treatment. In Figure 4,
patients are plotted with the same FPG at baseline, but given different evidence
with respect to having a variation in the OCT1 protein. On average, patients
in this population have a good chance that metformin is effective. However, for
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Fig. 3. Probabilistic simulation of metformin application to patients with different
fasting blood glucose (FPG) at baseline. Time of metformin application is varied as
well.
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Fig. 4. Probabilistic simulation of metformin application to patients with or without
a variation in the OCT1 protein.
the patients with the OCT1-variant, the chance that metformin is effective is
rather small and it might be better to prescribe an alternative drug, whereas for
patients with a normal OCT1 protein, metformin seems like a good choice. This
illustrates that such pharmacogenetics could thus be used for the personalisation
of treatments if tests for variations in the OCT1 protein become available.
5 Related works
5.1 Reasoning about Temporal Constraints
Many AI approaches focused their attention to the definition of suitable for-
malisms to represent time-related phenomena and to reason with them. Besides
“logical” approaches (e.g., temporal or non-monotonic logics), starting from the
early 80’s, many constraint-based approaches have been developed in AI [22].
Such approaches are mostly concerned to define domain-independent knowledge
servers which temporal reasoning, in the form of propagation of temporal con-
straints, can be delegated to, and which can be coupled with other modules (e.g.,
a planner, or a system which manages guidelines) to solve complex problems.
The aim towards specialization led these approaches to focus on specific
classes of constraints (e.g., qualitative constraints such as “A before B”, quan-
titative constraints such as dates, delays and durations) [22], or to devote great
attention to granularities and/or periodic/repeated constraints [23; 24; 25]) or to
the integration of different sorts of constraints (e.g., qualitative and quantitative
constraints [26]).
In the area of clinical guidelines several interesting approaches have been de-
vised to represent temporal constraints. For instance, GLIF[23] deals both with
temporal constraints on patient data elements and with duration constraints on
actions and decisions. In PROforma [24], guidelines are modelled as plans, and
each plan may define constraints on the accomplishment of tasks, as well as task
duration and delays between tasks. Moreover, temporal constructs can also be
used in order to specify the preconditions of actions. DILEMMA and PRES-
TIGE [3] model temporal constraints within conditions. EON [25] uses temporal
expressions to allow the scheduling of guideline steps, and deals with duration
constraints about activities. Moreover, by incorporating the RESUME system,
it provides a powerful approach to cope with temporal abstraction. In EON, the
Arden Syntax allows the representation of delays between the triggering event
and the activation of a Medical Logic Module (MDL), and between MDLs [26].
A rich ontology to deal with temporal information in clinical trial protocols
has been proposed in [27], considering also relative and indeterminate temporal
information and cyclical event patterns.
Despite the large amount of work devoted to the representation of temporal
constraints, and the very rich and expressive formalisms being identified, little
attention has been paid to temporal reasoning. Notable exceptions are repre-
sented by the approaches by Shahar [28] and by Duftschmid et al. [29].
In Shahar’s approach, the goal of temporal reasoning is not to deal with
temporal constraints (e.g., to check their consistency), but to find out proper
temporal abstractions to data and properties. Therefore, temporal reasoning is
not based on constraint propagation techniques, in fact, e.g., interpolation-based
techniques and knowledge-based reasoning are used.
Miksch et al. have proposed a comprehensive approach based on the no-
tion of temporal constraint propagation [28, 29]. In particular, in Miksch et al.’s
approach, different types of temporal constraints deriving from the schedul-
ing constraints in the guideline, from the hierarchical decomposition of actions
into their components and from the control-flow of actions in the guideline are
mapped onto an STP framework [4]. Temporal constraint propagation is used in
order to (1) detect inconsistencies, and to (2) provide the minimal constraints
between actions. In [29], there is also the claim that (3) such a method can
be used by the guideline interpreter in order to assemble feasible time intervals
for the execution of each guideline activity. Moreover, advanced visualization
techniques are used in order to show users the results of temporal reasoning [30].
5.2 Verification
Our work about model-checking verification has started in the context of the
Italian (two-years) project MIUR-PRIN 2003 “Logic-based development and
verification of multi-agent systems” whose main objective was the development
of logical and computational formalisms for the specification and verification
of agents and their interactions. Our approach to LTL verification of clinical
guidelines in SPIN has been described in detail in [31]. [[OK REF A AIMJ????]]
Automatic verification of clinical guidelines has first been explored in [9],
where a theorem proving approach is proposed to deal with the problem of pro-
tocol verification. This activity has been developed within the European projects
Protocure and Protocure II. Here, a medical protocol is modelled in the Asbru
language as a hierarchical plan and then it is mapped to a specification in KIV,
an interactive theorem prover for higher order logic. Properties are expressed
in a variant of Interval Temporal Logic. [2] has provided an evaluation of the
feasibility of this approach based on the formalization and verification of the
”jaundice” protocol and the ”diabetes mellitus” protocol.
In the Protocure II project, model checking techniques for the verification of
clinical guidelines have also been explored [10]. In contrast to interactive verifica-
tion, model checking is fully automatic. In particular, Protocure II exploits CTL
model checking and the tool SMV [32]. The Asbru model is translated into the
input language of SMV model checker by making use of a suitable abstraction
which eliminates time. The compiler takes the algebraic specification of Asbru
models in KIV as input and generates an SMV document. CTL model checking
is used in the verification of a wide range of properties of guidelines modelled
in Asbru, namely structural and medical properties. In particular, in [10] prop-
erties of the jaundice protocol are formalized as ACTL formulas (that is, CTL
formulas only allowing universal path quantifiers) [33].
The main difference between our approach and Protocure’s one is that our
approach is based on LTL temporal logic while Protocure’s one is based on CTL
temporal logic. The adoption of CTL (and ACTL) or LTL model checking al-
lows for the verification of different temporal properties, as CTL and LTL are
expressively incomparable (as well as ACTL and LTL).A further difference be-
tween our approach and Protocure one is due to the availability in SPIN of a
higher-level input language, as compared with the input language of SMV. The
fact that Promela is well suited for modelling guidelines as processes interact-
ing with their environment by exchanging messages over channels, substantially
simplifies the task of providing a translation of guidelines into Promela code
(which does not require intermediate levels of representation), as well as that of
interpreting the results of Concerning the type of the properties to be verified, as
observed in [10] the model checking approach is well suited for the verification
of structural and simple medical properties of the guideline, that normally do
not require an incremental verification strategy.
5.3 Probabilistic Verification
Since the last two decades, probabilistic graphical models, PGMs for short, have
become the state of the art for knowledge representation involving uncertainty.
PGMs, and in particular Bayesian and Markov networks, have been successfully
applied to various problem areas, including medicine. There is a considerable
body of work (e.g. [34–38]) indicating that Bayesian networks offer a natural and
intuitive formalism for constructing clinically relevant models. Unfortunately,
PGMs are unsuitable for capturing knowledge that goes beyond statistical de-
pendence and independence information, like clinical guidelines. In contrast, it
has been shown that CP-logic that the probabilistic verification introduced in
this chapter is based upon, can also represent various PGMs [19, 39].
With the recent introduction of probabilistic logics more powerful, relational
languages for the representation of uncertain knowledge have become available,
which are more suitable for dealing with combinations of logical and probabilistic
knowledge. For example, there now exist logical versions of Markov networks,
called Markov logic networks [40], and of Bayesian networks, called Bayesian
logic programs [41]. Influential is also Poole’s independent choice logic [42, 43],
in addition to ProbLog [44] and CP-Logic [19]. These probabilistic logics offer a
very natural and flexible choice for modelling complex domains involving uncer-
tainty. On the other, all these languages are general probabilistic logics and do
not deal with the particular requirements for representing CIGs, in particular
temporal information. A notable exception is CPT-L [45], where CP-logic is used
for modelling Markov models. The difference to our approach in the fact that in
CPT-L each rule determines a transition. In the logic proposed in this chapter,
each derivation determines a transition, which allows for richer modelling of the
transitions.
The CPDTL logic proposed here can also been as a hierarchical models,
with on the top-level a Markov model and in each state transition, a CP-logic
program. In this sense, logical hierarchical HMM (LoHiHMM) [46] can be seen
as a related appraoach. The difference with this approach is two-fold. In the
probabilistic sense, the LoHiHMM is more expressive, as it is a hidden Markov
model rather than a Markov chain. On the other hand, the logical representation
is weaker. LoHiHMMs are called logical, because each state is abstracted using
predicate logic, rather than a propositional state. However, logic is not used to
model the transitions, which makes it unsuitable to model the dynamic behaviour
using a symbolic language.
6 Conclusions
CIG are assuming an important role in the standardization and optimization of
healthcare. In particular, CIG system can be used by physicians as recommen-
dation tools, to provide high-quality medical treatments to patients, on the basis
of evidence-based medicine.
However, given the dimensions of CIGs (which may consist of hundreds of
inter-related actions), and the large amount of knowledge they contain, verifi-
cation is important to guarantee the quality of the provided recommendations.
As described in this chapter, verification is important at different stages in the
CIG life-cycle: during design and acquisition, to check structural and medical
validity properties, during contextualization, to support the adoption of general
CIGs in specific application contexts, and during execution, to look for the most
appropriate treatments of specific patients, possibly considering probabilistic in-
formation on treatments outcomes and patient evolutions.
In this chapter, we investigate such issues, proposing a range of methodologies
covering the different aspects of verification. The core idea of this chapter is that,
given the heterogeneous character of the knowledge contained in CIGs, different
forms of verifications should be supported, demanding for an hybrid approach in
which different representation formalisms are used (to properly capture different
types of knowledge) and different methodologies are devised (to properly reason
with the different formalisms). In particular, we focused on three different issues,
and methodologies.
Considering the temporal constraints in CIGs, we propose to adopt the clas-
sical AI approach to devise a specialized constraint-propagation-based temporal
reasoner [47, 48]. Such approaches focus on temporal constraints only, so that
specific representation formalisms can be devised, in such a way that correct
and complete temporal reasoning can be performed efficiently (in cubic time, in
our approach). While such approaches are advantageous when considering tem-
poral constraints only, they are not general enough to deal with more general
forms of knowledge, and of verification. We then considered the verification of
medical validity properties of CIGs, with emphasis on the temporal evolution
of CIGs actions. In such a context, we have proposed the adoption of model-
based verification techniques based on temporal logics (LTL), which proved to
be well-suited for many medical verification tasks. Last, but not least, we have
also considered the probabilistic component of medical knowledge, which is of
paramount importance especially when considering the application of CIGs to
specific patients, to identify those treatment which, probabilistically speaking,
are the best options for them. In such a context, we propose the Causal Prob-
abilistic Decision Time Logic, and show its adequacy to deal with probabilistic
verification in the medical context.
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